Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$7.90 USD
+0.04 (0.51%)
Updated May 22, 2024 04:00 PM ET
After-Market: $7.88 -0.02 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-1.27 | 0.00% |
Earnings Summary
For their last quarter, Adverum Biotechnologies (ADVM) reported earnings of -$1.50 per share, missing the Zacks Consensus Estimate of -$1.28 per share. This reflects a negative earnings surprise of 17.19%. Look out for ADVM's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$1.27 per share, reflecting a year-over-year increase of 59.03%.
Earnings History
Price & Consensus
Zacks News for ADVM
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services